Page last updated: 2024-08-22

aluminum sulfate and Urinary Tract Infections

aluminum sulfate has been researched along with Urinary Tract Infections in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Asadi Karam, MR; Farokhi, M; Habibi, M; Rezvanirad, A1
Asadi Karam, MR; Azimi, S; Habibi, M; Khoobbakht, D; Roghanian, P1
Asadi Karam, MR; Bouzari, S; Habibi, M1

Other Studies

3 other study(ies) available for aluminum sulfate and Urinary Tract Infections

ArticleYear
Immunogenic Potential and Therapeutic Efficacy of Multi-Epitope Encapsulated Silk Fibroin Nanoparticles against Pseudomonas aeruginosa-Mediated Urinary Tract Infections.
    Macromolecular bioscience, 2023, Volume: 23, Issue:9

    Topics: Adjuvants, Immunologic; Animals; Epitopes; Fibroins; Mice; Mice, Inbred BALB C; Nanoparticles; Pseudomonas aeruginosa; Urinary Tract Infections; Vaccines

2023
Immunization with recombinant protein Ag43::UpaH with alum and 1,25(OH)2D3 adjuvants significantly protects Balb/C mice against urinary tract infection caused by uropathogenic Escherichia coli.
    International immunopharmacology, 2021, Volume: 96

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Load; Bacterial Vaccines; Cholecalciferol; Cytokines; Escherichia coli Proteins; Immunity, Humoral; Immunization; Immunoglobulin G; Injections, Intravenous; Mice, Inbred BALB C; Mucous Membrane; Recombinant Fusion Proteins; Urinary Tract Infections; Uropathogenic Escherichia coli; Virulence Factors

2021
Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
    Microbial pathogenesis, 2017, Volume: 110

    Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Bacterial; Escherichia coli Infections; Escherichia coli Proteins; Escherichia coli Vaccines; Immunoglobulin G; Injections, Subcutaneous; Kidney; Mice; Receptors, Cell Surface; Treatment Outcome; Urinary Bladder; Urinary Tract Infections; Uropathogenic Escherichia coli

2017